MAGEA6 and neoplasm: According to the analyzes described for each marker separately above, combined analyzes also showed a significant association of various phenotypes of the MAGE-A6/MAGE-A11 with clinicopathological parameters including tumor size, histological grade, PT stage, LP involvement, and L/M involvement for both nuclear and cytoplasmic expression.